The latest headlines across every section, pulled from official and open-access sources.
Doxecitine and Doxribtimine in the treatment of paediatric and adult patients with thymidine kinase 2 deficiency (TK2d) with an age of symptom onset on or before 12 years.
Diagnostics specialist Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by earning a CE mark in Europe for its Access p-Tau217 assay.
Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire endocrine disease specialist Crinetics Pharmaceuticals. The transaction's two focuses, Palsonify and atumelnant, have combined peak sales potential of more than $5 billion, Vertex said.
ECDC is launching an updated data visualisation that predicts where the risk of being infected by Vibrio bacteria could be greatest.
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders have been left debating how they can navigate this shifting landscape—or even whether biotechs should abandon China altogether.
A software anomaly may cause a false battery-health value. The pump should remain plugged in at all times.
If dropped, the Ivenix pump touchscreen may become unresponsive and should be removed from use.
J. Ramassamy et al.
Psychiatry
Obstetrics and Gynecology
Health Informatics
This randomized clinical trial evaluates the effectiveness of hospital-based assertive case management as an adjunct to standard psychiatric treatment for patients with major depressive disorder presenting with suicidal ideation.
This cohort study estimates the incidence of recurrent invasive pneumococcal disease among adult patients in Canada and assesses risk factors for recurrence among patients with a primary episode of invasive pneumococcal disease.
This cohort study examines pain trajectories and patterns of opioid and nonopioid treatment use among opioid-naive patients who were offered an opioid prescription for acute pain in a variety of clinical settings.
This economic evaluation estimates the number of and costs associated with Medicare beneficiaries aged 65 years or older receiving care for HIV in the US from 2026 to 2035.
This cross-sectional study characterizes opioid analgesic prescribing trends in the US among commercially insured and Medicare Advantage patients by prescriber specialty, analyzing short-term and long-term opioid use episodes separately.
This nonrandomized clinical trial evaluates the association of interval salpingectomy with delayed oophorectomy vs risk-reducing salpingo-oophorectomy for ovarian cancer prevention with sexual function and menopausal symptoms.
This survey study reports on how US adolescents perceive risk related to different levels of fentanyl use.
This qualitative study examines patient perspectives about messages drafted by artificial intelligence (AI) in online patient portals to identify implications for patient-centered implementation.
Around a million families are being urged to protect their children against the spread of measles and other potentially deadly childhood illnesses, as part of a new NHS vaccination drive. Children aged from 12-months to 11 years old who have missed one or both doses of the vaccine, will be invited as part of the […]
A new report finds private equity firms are increasingly using joint ventures with nonprofit health systems to expand in healthcare, prompting calls for greater oversight. The post Report Highlights Private Equity’s Lesser-Known Strategy: Nonprofit Joint Ventures appeared first on MedCity News .
Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service. The health system says the goal is to free up time for patient care rather than information-gathering. The post Why Penn Medicine Is Deploying AI Agents for Patient Intake appeared first on MedCity News .
Learn about FDA’s innovative approaches to respond to COVID-19 as quickly and safely as possible.
Today, the FDA issued an emergency use authorization for the drug baricitinib, in combination with remdesivir, for the treatment of COVID-19 in hospitalized adults and pediatric patients 2+ years requiring supplemental oxygen, invasive mechanical ventilation, or ECMO.